SCHEMBL8896077

SCHEMBL8896077

CC(O)CCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10046626 0.91
SCHEMBL8773013 0.88
SCHEMBL8896798 0.88 TRPV1 (0.40)
SCHEMBL8896720 0.88 TRPV1 (0.40)
SCHEMBL28044629 0.88 TRPV1 (0.40)
SCHEMBL9052590 0.88 TRPV1 (0.40)
SCHEMBL2114208 0.80
SCHEMBL3914418 0.79
SCHEMBL2155981 0.79 TSHR (0.47)
SCHEMBL19293365 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104876896-A Intermediates for the preparation of analogs of halichondrin B EISAI R&D MAN CO LTD 2015-09-02 CN disclosed
CN-101172957-B Novel compound, synthetic method thereof and therapeutic usage GILEAD SCIENCES INC (US) 2012-11-14 CN disclosed
CN-100409844-C neuraminidase inhibitors GILEAD SCIENCES INC (US) 2008-08-13 CN disclosed
CN-101172957-A Selective inhibitors of viral or bacterial neuraminidase GILEAD SCIENCES INC (US) 2008-05-07 CN disclosed
CN-101143859-A Novel compound, its synthesis method and therapeutical uses GILEAD SCIENCES INC (US) 2008-03-19 CN disclosed
CN-100338031-C Compounds and methods for synthesis and therapy GILEAD SCIENCES INC (US) 2007-09-19 CN disclosed
CN-1733707-A Compounds and methods for synthesis and therapy GILEAD SCIENCES INC (US) 2006-02-15 CN disclosed
CN-1185223-C Novel compounds, their synthesis and therapeutic use GILEAD SCIENCES INC (US) 2005-01-19 CN disclosed
CN-1147813-A Novel compounds, their synthesis and therapeutic use GILEAD SCIENCES INC (US) 1997-04-16 CN disclosed
EP-0759917-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1997-03-05 EP disclosed